Zhejiang Starry Pharmaceutical Co., Ltd. Class A

Zhejiang Starry Pharmaceutical Co., Ltd. Class A

SSSE:603520
7.58
CNY
-0.16
(-2.07%)
0.06EPS
142.72P/E
3.84BMarket Cap
Apr 28Next Earn

Latest Stock Split

Jun 17, 2022

7:5

For every 5 shares held, investors received 7. The price per share adjusted from $42.67 to $30.48.

The split itself did not change the total investment value.

Use this split data in your app

Build with our data

Stock Split History

  1. Jun 17, 2022
    Before$42.67
    Split ratio7:5
    After$30.48
    Forward
  2. Jun 01, 2020
    Before$87.97
    Split ratio7:5
    After$62.84
    Forward
  3. Jun 25, 2019
    Before$34.05
    Split ratio7:5
    After$24.32
    Forward

About Zhejiang Starry Pharmaceutical Co., Ltd. Class A stock splits

Zhejiang Starry Pharmaceutical Co., Ltd. Class A (SSE:603520) operates in the Medical specialties industry.

Zhejiang Starry Pharmaceutical Co., Ltd. Class A company overview

When did Zhejiang Starry Pharmaceutical Co., Ltd. Class A stock split?

Zhejiang Starry Pharmaceutical Co., Ltd. Class A's most recent stock split was on June 17, 2022. It was a 7-for-5 forward split, so shareholders received 7 shares for every 5 they held.

What is Zhejiang Starry Pharmaceutical Co., Ltd. Class A's stock split history?

Zhejiang Starry Pharmaceutical Co., Ltd. Class A (SSE:603520) has split its stock 3 times: a 7-for-5 split on June 25, 2019, a 7-for-5 split on June 1, 2020, and a 7-for-5 split on June 17, 2022.

How many times has Zhejiang Starry Pharmaceutical Co., Ltd. Class A stock split?

Zhejiang Starry Pharmaceutical Co., Ltd. Class A has split its stock 3 times. This history records 3 forward splits between June 25, 2019 and June 17, 2022.

What is a stock split?

A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Zhejiang Starry Pharmaceutical Co., Ltd. Class A's 7-for-5 split on June 17, 2022, every 5 shares became 7 shares.

Will Zhejiang Starry Pharmaceutical Co., Ltd. Class A split its stock again?

Zhejiang Starry Pharmaceutical Co., Ltd. Class A has not announced a new split in our records. Its most recent split was on June 17, 2022, 4 years ago. Companies announce splits in advance, and any new SSE:603520 split will appear on this page.